Literature DB >> 10780960

Splice isoforms of alpha(1a)-adrenoceptor in rabbit.

F Suzuki1, T Taniguchi, R Takauji, S Murata, I Muramatsu.   

Abstract

Two splice isoforms of rabbit alpha(1a)-adrenergic receptor (AR), (named alpha(1a)-OCU.2-AR and alpha(1a)-OCU.3-AR) have been isolated from the liver cDNA library in addition to the previously reported isoform (alpha(1a)-OCU.1-AR). Although they have the identical splice position with human alpha(1a)-AR isoforms, the C-terminal sequences are distinct from those of human isoforms. Among these rabbit alpha(1a)-AR isoforms, there are no significant differences in pharmacological properties: high affinity for prazosin, WB4101, KMD-3213 and YM617 and low affinity for BMY7378, using COS-7 cells expressing each isoform by radioligand binding assay. Competitive reverse transcription-polymerase chain reaction (RT - PCR) analysis revealed that mRNA of alpha(1a)-ARs was expressed in liver, thoracic aorta, brain stem and thalamus of rabbit. The splice isoforms exhibited a distinct distribution pattern in rabbit; alpha(1a)-OCU. 1-AR was expressed most abundantly in those tissues. CHO clones, stably expressing each isoforms with receptor density 740 fmol mg(-1) protein in alpha(1a)-OCU.1-AR, 1200 fmol mg(-1) in alpha(1a)-OCU.2-AR and 570 fmol mg(-1) in alpha(1a)-OCU.3-AR, respectively, showed a noradrenaline-induced increase in inositol trisphosphate which was suppressed by prazosin. Noradrenaline elicited a concentration-dependent increase in extracellular acidification rate (EAR) in the CHO clones with pEC(50) values of 6. 19 for alpha(1a)-OCU.1-AR, 6.49 for alpha(1a)-OCU.2-AR and 6.58 for alpha(1a)-OCU.3-AR, respectively. Noradrenaline caused a concentration-dependent increase in intracellular Ca(2+) concentration ([Ca(2+)]i) in the CHO clones with pEC(50) values of 6. 14 for alpha(1a)-OCU.1-AR, 7.25 for alpha(1a)-OCU.2-AR and 7.70 for alpha(1a)-OCU.3-AR, respectively. In conclusion, the present study shows the occurrence of three splice isoforms of rabbit alpha(1a)-AR, which are unique in C-terminal sequence and in tissue distribution. They show similar pharmacological profiles in binding studies but alpha(1a)-OCU.3-AR had the highest potency of noradrenaline in functional studies in spite of the lowest receptor density. These findings suggest that the structure of C-terminus of alpha(1a)-ARs may give the characteristic functional profile.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780960      PMCID: PMC1572000          DOI: 10.1038/sj.bjp.0703242

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

2.  Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA.

Authors:  D M Perez; M T Piascik; R M Graham
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

Review 3.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

4.  Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D.

Authors:  D G Rokosh; B A Bailey; A F Stewart; L R Karns; C S Long; P C Simpson
Journal:  Biochem Biophys Res Commun       Date:  1994-05-16       Impact factor: 3.575

5.  Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor.

Authors:  A Hirasawa; K Horie; T Tanaka; K Takagaki; M Murai; J Yano; G Tsujimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

Review 6.  Alpha 1-adrenoceptor classification: sharpening Occam's razor.

Authors:  A P Ford; T J Williams; D R Blue; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1994-06       Impact factor: 14.819

7.  Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.

Authors:  J W Lomasney; S Cotecchia; W Lorenz; W Y Leung; D A Schwinn; T L Yang-Feng; M Brownstein; R J Lefkowitz; M G Caron
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

8.  The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype.

Authors:  T M Laz; C Forray; K E Smith; J A Bard; P J Vaysse; T A Branchek; R L Weinshank
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

9.  Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.

Authors:  D A Schwinn; G I Johnston; S O Page; M J Mosley; K H Wilson; N P Worman; S Campbell; M D Fidock; L M Furness; D J Parry-Smith
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

10.  Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.

Authors:  D T Price; R S Chari; D E Berkowitz; W C Meyers; D A Schwinn
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

View more
  9 in total

1.  Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes.

Authors:  Fumiko Suzuki; Takanobu Taniguchi; Seigo Nakamura; Yoshio Akagi; Chikara Kubota; Makoto Satoh; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  What makes the α(1A)-adrenoceptor gene express the α(1L)-adrenoceptor functional phenotype?

Authors:  Sabatino Ventura
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 3.  What makes the α1A -adrenoceptor gene product assume an α1L -adrenoceptor phenotype?

Authors:  Carl W White; Edilson Dantas da Silva Junior; Linzi Lim; Sabatino Ventura
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

Review 4.  Phenotype pharmacology of lower urinary tract α(1)-adrenoceptors.

Authors:  A Nishimune; H Yoshiki; J Uwada; A S M Anisuzzaman; H Umada; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors:  S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Inverse agonism and neutral antagonism at a constitutively active alpha-1a adrenoceptor.

Authors:  J Zhu; T Taniguchi; R Takauji; F Suzuki; T Tanaka; I Muramatsu
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats.

Authors:  Li Zhang; Takanobu Taniguchi; Takashi Tanaka; Kazumasa Shinozuka; Masaru Kunitomo; Masahiko Nishiyama; Koji Kamata; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

8.  The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate.

Authors:  Kt Gray; Jl Short; S Ventura
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

9.  Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.

Authors:  Sanam Mustafa; Heng B See; Ruth M Seeber; Stephen P Armstrong; Carl W White; Sabatino Ventura; Mohammed Akli Ayoub; Kevin D G Pfleger
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.